World News Today

India news, world news, sports news, entertainment news,

Trial shows a steroid reduces deaths from severe cases

The number of confirmed cases of the coronavirus around the world has now topped 8 million as the World Health Organization continues to warn that, while the virus has slowed in parts of Europe, it is gaining speed in other parts of the world, including parts of Africa and the Americas. More than 100,000 new cases are reported globally every day, the WHO said Monday.

This is CNBC’s live blog covering all the latest news on the coronavirus outbreak. This blog will be updated throughout the day as the news breaks. 

  • Global cases: More than 8.06 million
  • Global deaths: At least 437,532
  • U.S. cases: More than 2.11 million
  • U.S. deaths: At least 116,127

The data above was compiled by Johns Hopkins University.

One in five people worldwide are at risk of developing ‘severe’ cases of Covid-19, scientists claim

Doctors wearing face masks and gloves as a preventive measure attend to a coronavirus patient at the intensive care unit of Albert Schweitzer Hospital.

Robin Utrecht | SOPA Images | LightRocket via Getty Images

9:50 a.m. ET — One in five people worldwide are at risk of developing severe cases of Covid-19, scientists have estimated.

A team of researchers from the U.S., the U.K. and China estimated that 1.7 billion people — or 22% of the global population — are at “increased risk” of developing severe symptoms if infected with the coronavirus.

People were considered to be at increased risk if they had one or more chronic health conditions associated with greater vulnerability to the virus, such as diabetes or cardiovascular disease.

In North America, 28% of the population, or 104 million people, had at least one underlying condition that put them at increased risk of developing severe Covid-19 if they caught the virus, according to the study. —Chloe Taylor

Steroid dexamethasone reduces deaths from severe Covid-19, trial shows

9:41 a.m. ET — Treating Covid-19 patients with the generic steroid dexamethasone cut death rates by about a third for those with the most serious cases of the virus, according to data from a UK-led clinical trial.

Scientists have called the results a “major breakthrough” and the study’s researchers said the generic drug should become standard care in hospitalized coronavirus patients, Reuters reports.

There are currently no approved vaccines or treatments for the coronavirus. —Hannah Miller, Reuters

CNBC Disruptor 50 list features companies focused on coronavirus economy

9:22 a.m. ET — This year’s CNBC Disruptor 50 list includes at least 18 companies that say demand for their core products has more than doubled since the coronavirus crisis unleashed itself across the world. That’s because many use artificial intelligence and machine learning, which are speeding the development of medical treatments to fight the virus.

Others are in the health-technology field supporting at-home testing, such as, which provides FDA-approved remote urinalysis, and Heal, a six-year-old start-up that provides at-home doctor visits through telemedicine., a company that is so defined by artificial intelligence that it changed its name from C3 IoT a few years ago, has taken a leading role in using the technology to fight Covid-19.

The three-time Disruptor 50 company teamed up with Amazon Web Services in April to create a Covid-19 “data lake,” which unifies data sets, updates them in real-time and offers researchers a clearer starting point for generating usable insights.

Tempus built a drug discovery-and-development platform designed to be disease-agnostic. So when the pandemic hit, it was in a strong position to pivot and support efforts to slow the spread and to find short-term and long-term treatments.

Tempus brought a test to market in April and launched a research project examining 50,000 coronavirus-positive patients to find the most effective treatments and other insights. —Lori Ioannou

AstraZeneca’s Covid-19 vaccine protects for one year, CEO says

AstraZeneca’s building in Luton, Britain.

Tim Ireland | Xinhua News Agency | Getty Images

8:58 a.m. ET — AstraZeneca‘s coronavirus vaccine would provide protection from contracting Covid-19 for around one year, CEO Pascal Soriot told Belgian radio station Bel RTL Tuesday.

The company has contracts with France, Germany, Italy, the Netherlands, the U.S. and Britain to provide doses of the vaccine, Reuters reported.

Soriot said the vaccine could be ready, beginning October, “if all goes well.”

Soriot told the station, in an interview curated by Reuters, that the company has already begun a phase III trial and has a phase I trial ending soon. —Alex Harring

Coronavirus could usher in cashless casinos

Guests play roulette at Excalibur Hotel & Casino after the Las Vegas Strip property opened for the first time since being closed in mid-March because of the coronavirus (COVID-19) pandemic on June 11, 2020 in Las Vegas, Nevada.

Ethan Miller | Getty Images

8:32 a.m. ET — Concerns around Covid-19 could soon usher in cashless payment technologies ato Nevada casinos, with the Centers for Disease Control and Prevention recommending “tap-and-pay to limit handling of cash” to decrease the spread of the virus.

A hearing on cashless payments will be held for Nevada gaming regulators on June 25, CNBC’s Contessa Brewer reports.

Sightline Payments founder and CEO Kirk Sanford said contactless payments may even replace the chips at casino tables. While some say digital payments increase the risk of problem gambling, others see the benefit in increased hygienic practices in fighting the virus as well as the possibility to attract a younger generation of customers.

“Any customers uneasy about using cash on the gaming floor due to health or safety concerns should have an alternate payment option available to them,” the gaming industry’s trade group said. —Suzanne Blake

Ad spending decline won’t be as steep this year as it was in 2009 financial crisis, GroupM forecasts 

McDonald’s U.S. same-store sales fell just 5.1% in May

8:21 a.m. ET — McDonald’s U.S. customers are coming back to restaurants for their Big Macs and fries.

In May, the fast-food chain’s U.S. same-store sales fell just 5.1%. That’s in comparison with a 19.2% plunge in April, its steepest monthly drop during the pandemic.

Roughly 7% of McDonald’s U.S. locations have reopened with reduced seating capacity, and only about 100 restaurants in the country remain closed entirely.

But outside of the U.S., widespread temporary closures shuttered even drive-thru and delivery service, leading same-store sales of its two international segments to plunge. As of Monday, 90% of its international restaurants are operating again. —Amelia Lucas

The latest on U.S. hot spots

Sanofi to invest more than $670 million in vaccine research centers

The logo of Sanofi is seen at the company’s research and production centre in Vitry-sur-Seine, France, August 6, 2019.

Charles Platiau | Reuters

7:21 a.m. ET — French drugmaker Sanofi will invest $679.4 million in two French facilities to turn them into a “state-of-the-art vaccine production” site and a new vaccine research center, the company announced.

Sanofi said the investment was made possible by “close collaboration with French authorities” over the past few months and will help the company respond quickly to any future pandemic viruses. 

“Sanofi is a major healthcare player in France, in Europe, and worldwide,” Sanofi CEO Paul Hudson said. It is our responsibility to focus our resources and expertise against the current pandemic, but also to invest in preparing for future ones.”

Sanofi and pharmaceutical company GlaxoSmithKline announced in April plans to join the race for a Covid-19 vaccine. —Will Feuer

German demand for potatoes down amid pandemic

A customer stands beside a chilled meat cabinet inside a Rewe supermarket, operated by the Rewe Group, in Berlin, Germany.

Krisztian Bocsi | Bloomberg | Getty Images

6:56 a.m. ET — The pandemic has hit German demand for potatoes and related products hard with around several 100,000 tons of products going to waste, the German Association of the Fruit, Vegetable and Potato Processing Industry (BOGK) said. It also called for the German government, and consumers, to support the potato market.

“Due to the catastrophic drop in sales of frozen, chilled and dry potato products, mainly in the areas of gastronomy, canteen supplies, consumption at major events and in exports, several 100,000 tons of processed potatoes could not be used not only in Europe but also in Germany,” the BOGK said.

“The consequences are serious,” Horst-Peter Karos, managing director of the association said. “The damage for this goes into the millions. A significant improvement in the situation is also not foreseeable in the medium term,” he added.

The association is asking both retailers and consumers “for a completely new appreciation for potatoes and potato products made from them. Retailers should therefore expand and promote the range of potato products overall.” It also asked for more government support for the potato processing industry. —Holly Ellyatt

Read CNBC’s previous coronavirus live coverage here: China reports 40 new cases as Beijing cluster grows, San Francisco moves further into reopening

Leave a Reply

Your email address will not be published. Required fields are marked *